Telix Pharmaceuticals Limited (GETTEX:T3X) IPO
IPO
Withdrawn on Jun 14, 2024. Filed with the SEC to go public on May 17, 2024.
- ADSs offered
- 17,000,000 American depositary shares
- Listing
- TLX on the Nasdaq Global Market · Has applied to list
- Underwriters
- Jefferies, Morgan Stanley, Truist Securities, William Blair · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jan 25, 2024 |
| Filed publicly | May 17, 2024 |
| Amended once | Jun 5, 2024 |
| Filing withdrawn | Jun 14, 2024 |
Filings
| Filing | Filed |
|---|---|
| RW · Request to withdraw a registration | Jun 14, 2024 |
| 8-A12B · Registration of shares for listing on an exchange | Jun 10, 2024 |
| F-1/A · Registration statement, amended | Jun 5, 2024 |
| F-1 · Registration statement | May 17, 2024 |
| DRS/A · Draft registration statement, amended | May 9, 2024 |
| DRS/A · Draft registration statement, amended | Apr 15, 2024 |
| DRS/A · Draft registration statement, amended | Mar 15, 2024 |
| DRS/A · Draft registration statement, amended | Feb 2, 2024 |
| DRS · Draft registration statement | Jan 25, 2024 |
From the cover of the amended prospectus (F-1/A) filed Jun 5, 2024